Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
Clinical trial NCT02822105 · COMPLETED
Trial details
- NCT number
- NCT02822105
- Sponsor
- FluGen Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-04-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.